Loading...

We've got a brand new version of Simply Wall St! Try it out

Siemens Healthineers

SWX:SHL
Snowflake Description

Adequate balance sheet with acceptable track record.

The Snowflake is generated from 30 checks in 5 different areas, read more below.
SHL
SWX
€44B
Market Cap
  1. Home
  2. CH
  3. Healthcare
Company description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services worldwide. The last earnings update was 10 days ago. More info.


Add to Portfolio Compare Print
SHL Share Price and Events
7 Day Returns
0%
SWX:SHL
0.7%
CH Medical Equipment
-0.4%
CH Market
1 Year Returns
-7.4%
SWX:SHL
33.3%
CH Medical Equipment
12.3%
CH Market
SHL Shareholder Return
  7 Day 30 Day 90 Day 1 Year 3 Year 5 Year
Siemens Healthineers (SHL) 0% 0% 0% -7.4% - -
CH Medical Equipment 0.7% 2.5% 4.3% 33.3% 85.6% 109.4%
CH Market -0.4% 2.6% 6.7% 12.3% 21.5% 13.4%
1 Year Return vs Industry and Market
  • SHL underperformed the Medical Equipment industry which returned 33.3% over the past year.
  • SHL underperformed the Market in Switzerland which returned 12.3% over the past year.
Price Volatility
Industry
5yr Volatility vs Market

SHL Value

 Is Siemens Healthineers undervalued based on future cash flows and its price relative to the stock market?

Value is all about what a company is worth versus what price it is available for. If you went into a grocery store and all the bananas were on sale at half price, they could be considered undervalued.
INTRINSIC VALUE BASED ON FUTURE CASH FLOWS
Here we compare the current share price of Siemens Healthineers to its discounted cash flow analysis.value.

The discounted cash flow value is simply looking at what the company is worth today, based on estimates of how much money it is expected to make in the future.
Raw Data

Below are the data sources, inputs and calculation used to determine the intrinsic value for Siemens Healthineers.

SWX:SHL Discounted Cash Flow Data Sources
Data Point Source Value
Valuation Model 2 Stage Free Cash Flow to Equity
Levered Free Cash Flow Average of 19 Analyst Estimates (S&P Global) See below
Discount Rate (Cost of Equity) See below 8.8%
Perpetual Growth Rate 10-Year CH Government Bond Rate 3.3%

An important part of a discounted cash flow is the discount rate, below we explain how it has been calculated.

Calculation of Discount Rate/ Cost of Equity for SWX:SHL
Data Point Calculation/ Source Result
Risk-Free Rate 10-Year CH Govt Bond Rate 3.3%
Equity Risk Premium S&P Global 6%
Medical Equipment Unlevered Beta Simply Wall St/ S&P Global 0.84
Re-levered Beta = Unlevered beta (1 + (1- tax rate) (Debt/Equity))
= 0.84 (1 + (1- 30%) (9.58%))
0.93
Levered Beta Levered Beta limited to 0.8 to 2.0
(practical range for a stable firm)
0.93
Discount Rate/ Cost of Equity = Cost of Equity = Risk Free Rate + (Levered Beta * Equity Risk Premium)
= 3.28% + (0.93 * 5.96%)
8.82%

Discounted Cash Flow Calculation for SWX:SHL using 2 Stage Free Cash Flow to Equity Model

The calculations below outline how an intrinsic value for Siemens Healthineers is arrived at by discounting future cash flows to their present value using the 2 stage method. We try to start with analysts estimates of free cash flow, however if these are not available we use the most recent financial results. In the 1st stage we continue to grow the free cash flow over a 10 year period, with the growth rate trending towards the perpetual growth rate used in the 2nd stage. The 2nd stage assumes the company grows at a stable rate into perpetuity.

Note: Free cash flow to equity valuations ignore the company's cash or debt.

SWX:SHL DCF 1st Stage: Next 10 year cash flow forecast
Levered FCF (EUR, Millions) Source Present Value
Discounted (@ 8.82%)
2020 1,587.83 Analyst x6 1,459.13
2021 1,748.18 Analyst x11 1,476.27
2022 2,069.33 Analyst x3 1,605.82
2023 2,435.50 Analyst x2 1,736.78
2024 2,720.00 Analyst x2 1,782.44
2025 2,939.64 Est @ 8.07% 1,770.23
2026 3,134.68 Est @ 6.63% 1,734.67
2027 3,311.07 Est @ 5.63% 1,683.77
2028 3,474.02 Est @ 4.92% 1,623.43
2029 3,627.83 Est @ 4.43% 1,557.90
Present value of next 10 years cash flows €16,430.00
SWX:SHL DCF 2nd Stage: Terminal Value
Calculation Result
Terminal Value = FCF2029 × (1 + g) ÷ (Discount Rate – g)
= €3,627.83 × (1 + 3.28%) ÷ (8.82% – 3.28%)
€67,561.39
Present Value of Terminal Value = Terminal Value ÷ (1 + r)10
= €67,561.39 ÷ (1 + 8.82%)10
€29,012.80
SWX:SHL Total Equity Value
Calculation Result
Total Equity Value = Present value of next 10 years cash flows + Terminal Value
= €16,430.00 + €29,012.80
€45,442.80
Equity Value per Share
(EUR)
= Total value / Shares Outstanding
= €45,442.80 / 998.45
€45.51
SWX:SHL Discount to Share Price
Calculation Result
Non-primary Listing Adjustment Factor 1 share in SWX:SHL represents 0.93778x of XTRA:SHL
(This could be a different class, a depositary receipt, a different currency, or all of these things.)
0.93778x
Value per Share
(Listing Adjusted, CHF)
= Value per Share (EUR) x Listing Adjustment Factor
= € 45.51 x 0.93778
CHF42.68
Value per share (CHF) From above. CHF42.68
Current discount Discount to share price of CHF40.92
= -1 x (CHF40.92 - CHF42.68) / CHF42.68
4.1%

Learn more about our DCF calculations in Simply Wall St’s analysis model .

Current Discount
Amount off the current price Siemens Healthineers is available for.
Intrinsic value
4%
Share price is CHF40.92 vs Future cash flow value of CHF42.68
Current Discount Checks
For Siemens Healthineers to be considered undervalued it must be available for at least 20% below the current price. Less than 40% is even better.
  • Siemens Healthineers's share price is below the future cash flow value, but not at a moderate discount (< 20%).
  • Siemens Healthineers's share price is below the future cash flow value, but not at a substantial discount (< 40%).
PRICE RELATIVE TO MARKET
We can also value a company based on what the stock market is willing to pay for it. This is similar to the price of fruit (e.g. Mangoes or Avocados) increasing when they are out of season, or how much your home is worth.

The amount the stock market is willing to pay for Siemens Healthineers's earnings, growth and assets is considered below, and whether this is a fair price.
Price based on past earnings
Are Siemens Healthineers's earnings available for a low price, and how does this compare to other companies in the same industry?
Raw Data
SWX:SHL PE (Price to Earnings) Ratio Data Sources
Data Point Source Value
Earnings Per Share * Company Filings (2019-09-30) in EUR €1.57
XTRA:SHL Share Price ** XTRA (2019-11-14) in EUR €43.64
Switzerland Medical Equipment Industry PE Ratio Median Figure of 7 Publicly-Listed Medical Equipment Companies 33.29x
Switzerland Market PE Ratio Median Figure of 171 Publicly-Listed Companies 19.37x

* Trailing twelve months (TTM) annual GAAP earnings per share excluding extraordinary items.

** Primary Listing of Siemens Healthineers.

SWX:SHL PE (Price to Earnings) Ratio Calculation
Calculation Outcome
PE Ratio

= XTRA:SHL Share Price ÷ EPS (both in EUR)

= 43.64 ÷ 1.57

27.79x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Siemens Healthineers is good value based on earnings compared to the CH Medical Equipment industry average.
  • Siemens Healthineers is overvalued based on earnings compared to the Switzerland market.
Price based on expected Growth
Does Siemens Healthineers's expected growth come at a high price?
Raw Data
SWX:SHL PEG (Price to Earnings to Growth) Ratio Data Sources
Data Point Source Value
PE Ratio See PE Ratio Section 27.79x
Net Income Annual Growth Rate See Future Growth Section.
Line of Best Fit* through Consensus Estimate Earnings of 19 Analysts
10%per year
Switzerland Medical Equipment Industry PEG Ratio Median Figure of 6 Publicly-Listed Medical Equipment Companies 2.34x
Switzerland Market PEG Ratio Median Figure of 124 Publicly-Listed Companies 2.14x

*Line of best fit is calculated by linear regression .

SWX:SHL PEG (Price to Earnings to Growth) Ratio Calculation
Calculation Outcome
PEG Ratio

= PE Ratio ÷ Net Income Annual Growth Rate

= 27.79x ÷ 10%

2.78x

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Siemens Healthineers is poor value based on expected growth next year.
Price based on value of assets
What value do investors place on Siemens Healthineers's assets?
Raw Data
SWX:SHL PB (Price to Book) Ratio Data Sources
Data Point Source Value
Book Value per Share Company Filings (2019-09-30) in EUR €9.71
XTRA:SHL Share Price * XTRA (2019-11-14) in EUR €43.64
Switzerland Medical Equipment Industry PB Ratio Median Figure of 9 Publicly-Listed Medical Equipment Companies 6.21x
Switzerland Market PB Ratio Median Figure of 214 Publicly-Listed Companies 1.65x
SWX:SHL PB (Price to Book) Ratio Calculation
Calculation Outcome
PB Ratio

= XTRA:SHL Share Price ÷ Book Value per Share (both in EUR)

= 43.64 ÷ 9.71

4.5x

* Primary Listing of Siemens Healthineers.

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • Siemens Healthineers is good value based on assets compared to the CH Medical Equipment industry average.
X
Value checks
We assess Siemens Healthineers's value by looking at:
  1. Is the discounted cash flow value less than 20%, or 40% of the share price? (2 checks) ( Click here or on bar chart for details of DCF calculation. )
  2. Is the PE ratio less than the market average, and/ or less than the Medical Equipment industry average (and greater than 0)? (2 checks)
  3. Is the PEG ratio within a reasonable range (0 to 1)? (1 check)
  4. Is the PB ratio less than the Medical Equipment industry average (and greater than 0)? (1 check)
  5. Siemens Healthineers has a total score of 2/6, see the detailed checks below.

    Note: We use GAAP Earnings per Share in all our calculations including PE and PEG Ratio.

    Full details on the Value part of the Simply Wall St company analysis model.

SHL Future Performance

 How is Siemens Healthineers expected to perform in the next 1 to 3 years based on estimates from 19 analysts?

The future performance of a company is measured in the same way as past performance, by looking at estimated growth and how much profit it is expected to make.

Future estimates come from professional analysts. Just like forecasting the weather, they don’t always get it right!
Annual Growth Rate
10%
Expected annual growth in earnings.
Earnings growth vs Low Risk Savings
Is Siemens Healthineers expected to grow at an attractive rate?
  • Siemens Healthineers's earnings growth is expected to exceed the low risk savings rate of 3.3%.
Growth vs Market Checks
  • Siemens Healthineers's earnings growth is expected to exceed the Switzerland market average.
  • Siemens Healthineers's revenue growth is expected to exceed the Switzerland market average.
Annual Growth Rates Comparison
Raw Data
SWX:SHL Future Growth Rates Data Sources
Data Point Source Value (per year)
SWX:SHL Future Earnings Growth Rate Line of Best Fit* through Consensus Estimate Earnings of 19 Analysts 10%
SWX:SHL Future Revenue Growth Rate Line of Best Fit* through Consensus Estimate Revenue of 19 Analysts 5.2%
Switzerland Medical Equipment Industry Earnings Growth Rate Market Cap Weighted Average 38.7%
Switzerland Medical Equipment Industry Revenue Growth Rate Market Cap Weighted Average 7.3%
Switzerland Market Earnings Growth Rate Market Cap Weighted Average 9.9%
Switzerland Market Revenue Growth Rate Market Cap Weighted Average 3.6%

*Line of best fit is calculated by linear regression .

Industry and Market average data is calculated daily.

Learn more about our growth rate calculations in Simply Wall St’s analysis model.

Analysts growth expectations
Raw Data
SWX:SHL Analysts Growth Expectations Data Sources
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 19 Analyst Estimates (S&P Global) See Below
All numbers in EUR Millions and using Trailing twelve months (TTM) annual period rather than quarterly.
SWX:SHL Future Estimates Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income * Avg. No. Analysts
2024-09-30 19,118 3,434 2,766 3
2023-09-30 17,986 2,952 2,425 4
2022-09-30 16,947 2,637 2,125 8
2021-09-30 15,939 2,433 1,889 18
2020-09-30 15,184 2,034 1,706 19
2019-11-14
SWX:SHL Past Financials Data
Date (Data in EUR Millions) Revenue Cash Flow Net Income *
2019-09-30 14,518 1,617 1,567
2019-06-30 14,080 1,643 1,435
2019-03-31 13,811 1,659 1,372
2018-12-31 13,532 1,593 1,299
2018-09-30 13,429 1,595 1,265
2018-06-30 13,372 1,429 1,295
2018-03-31 13,379 1,614 1,330
2017-12-31 13,548 1,741 1,327
2017-09-30 13,677 1,975 1,379

*GAAP earnings excluding extraordinary items.

Super high growth metrics
High Growth Checks
  • Siemens Healthineers's earnings are expected to grow by 10% yearly, however this is not considered high growth (20% yearly).
  • Siemens Healthineers's revenue is expected to grow by 5.2% yearly, however this is not considered high growth (20% yearly).
Past and Future Earnings per Share
The accuracy of the analysts who estimate the future performance data can be gauged below. We look back 3 years and see if they were any good at predicting what actually occurred. We also show the highest and lowest estimates looking forward to see if there is a wide range.
Raw Data
SWX:SHL Past and Future Earnings per Share
Data Point Source Value
Past Financials Company Filings (1 month ago) See Below
Future Estimates Average of up to 19 Analyst Estimates (S&P Global) See Below

All data from Siemens Healthineers Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SWX:SHL Future Estimates Data
Date (Data in EUR Millions) EPS * EPS High Estimate EPS Low Estimate Avg. No. Analysts
2024-09-30 2.77 2.77 2.77 1.00
2023-09-30 2.43 2.54 2.35 3.00
2022-09-30 2.13 2.30 1.97 5.00
2021-09-30 1.91 2.03 1.77 12.00
2020-09-30 1.73 1.86 1.62 11.00
2019-11-14
SWX:SHL Past Financials Data
Date (Data in EUR Millions) EPS *
2019-09-30 1.57
2019-06-30 1.43
2019-03-31 1.37
2018-12-31 1.30
2018-09-30 1.27
2018-06-30 1.30
2018-03-31 1.33
2017-12-31 1.34
2017-09-30 1.38

*GAAP earnings excluding extraordinary items.

Performance in 3 years
In the same way as past performance we look at the future estimated return (profit) compared to the available funds. We do this looking forward 3 years.
  • Siemens Healthineers is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
X
Future performance checks
We assess Siemens Healthineers's future performance by looking at:
  1. Is the annual earnings growth rate expected to beat the low risk savings rate, plus a premium to keep pace with inflation?
  2. Is the annual earnings growth rate expected to beat the average growth rate in earnings of the Switzerland market? (1 check)
  3. Is the annual revenue growth rate expected to beat the average growth rate in revenue of the Switzerland market? (1 check)
  4. Is the annual earnings growth rate expected to be above 20%? (1 check)
  5. Is the annual revenue growth rate expected to be above 20%? (1 check)
  6. Is the Return on Equity in 3 years expected to be over 20%? (1 check)
Some of the above checks will fail if the company is expected to be loss making in the relevant year.
Siemens Healthineers has a total score of 3/6, see the detailed checks below.

Note 1: We use GAAP Net Income Excluding Exceptional Items for our Earnings in all our calculations.

Full details on the Future part of the Simply Wall St company analysis model.

SHL Past Performance

  How has Siemens Healthineers performed over the past 5 years?

The past performance of a company can be measured by how much growth it has experienced and how much profit it makes relative to the funds and assets it has available.
Past earnings growth
Below we compare Siemens Healthineers's growth in the last year to its industry (Medical Equipment).
Past Earnings growth analysis
We also check if the company has grown in the past 5 years, and whether it has maintained that growth in the year.
  • Siemens Healthineers's year on year earnings growth rate has been positive over the past 5 years.
  • Siemens Healthineers's 1-year earnings growth exceeds its 5-year average (23.9% vs 3%)
  • Siemens Healthineers's earnings growth has exceeded the CH Medical Equipment industry average in the past year (23.9% vs -9.5%).
Earnings and Revenue History
Siemens Healthineers's revenue and profit over the past 5 years is shown below, any years where they have experienced a loss will show up in red.
Raw Data

All data from Siemens Healthineers Company Filings, last reported 1 month ago, and in Trailing twelve months (TTM) annual period rather than quarterly.

SWX:SHL Past Revenue, Cash Flow and Net Income Data
Date (Data in EUR Millions) Revenue Net Income * G+A Expenses R&D Expenses
2019-09-30 14,518.00 1,567.00 2,214.00 1,328.00
2019-06-30 14,080.00 1,435.00 2,197.00 1,308.00
2019-03-31 13,811.00 1,372.00 2,160.00 1,301.00
2018-12-31 13,532.00 1,299.00 2,151.00 1,287.00
2018-09-30 13,429.00 1,265.00 2,153.00 1,281.00
2018-06-30 13,372.00 1,295.00 2,155.00 1,281.00
2018-03-31 13,379.00 1,330.00 2,178.00 1,261.00
2017-12-31 13,548.00 1,327.00 2,224.00 1,265.00
2017-09-30 13,677.00 1,379.00 2,222.00 1,253.00
2016-09-30 13,547.00 1,311.00 2,206.00 1,145.00
2015-09-30 12,936.00 1,277.00 2,109.00 1,055.00

*GAAP earnings excluding extraordinary items.

Performance last year
We want to ensure a company is making the most of what it has available. This is done by comparing the return (profit) to a company's available funds, assets and capital.
  • Siemens Healthineers has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
  • Siemens Healthineers used its assets less efficiently than the CH Medical Equipment industry average last year based on Return on Assets.
  • Siemens Healthineers's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
X
Past performance checks
We assess Siemens Healthineers's performance over the past 5 years by checking for:
  1. Has earnings increased in past 5 years? (1 check)
  2. Has the earnings growth in the last year exceeded that of the Medical Equipment industry? (1 check)
  3. Is the recent earnings growth over the last year higher than the average annual growth over the past 5 years? (1 check)
  4. Is the Return on Equity (ROE) higher than 20%? (1 check)
  5. Is the Return on Assets (ROA) above industry average? (1 check)
  6. Has the Return on Capital Employed (ROCE) increased from 3 years ago? (1 check)
The above checks will fail if the company has reported a loss in the most recent earnings report. Some checks require at least 3 or 5 years worth of data.
Siemens Healthineers has a total score of 3/6, see the detailed checks below.

Note: We use GAAP Net Income excluding extraordinary items in all our calculations.

Full details on the Past part of the Simply Wall St company analysis model.

SHL Health

 How is Siemens Healthineers's financial health and their level of debt?

A company's financial position is much like your own financial position, it includes everything you own (assets) and owe (liabilities).

The boxes below represent the relative size of what makes up Siemens Healthineers's finances.

The net worth of a company is the difference between its assets and liabilities.
Net Worth
  • Siemens Healthineers is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Siemens Healthineers's cash and other short term assets cover its long term commitments.
Balance sheet
This treemap shows a more detailed breakdown of Siemens Healthineers's finances. If any of them are yellow this indicates they may be out of proportion and red means they relate to one of the checks below.
Assets
Liabilities and shares
The 'shares' portion represents any funds contributed by the owners (shareholders) and any profits.
  • High level of physical assets or inventory.
  • Debt is covered by short term assets, assets are 1.9x debt.
Historical Debt
Nearly all companies have debt. Debt in itself isn’t bad, however if the debt is too high, or the company can’t afford to pay the interest on its debts this may have impacts in the future.

The graphic below shows equity (available funds) and debt, we ideally want to see the red area (debt) decreasing.

If there is any debt we look at the companies capability to repay it, and whether the level has increased over the past 5 years.
Raw Data

All data from Siemens Healthineers Company Filings, last reported 1 month ago.

SWX:SHL Past Debt and Equity Data
Date (Data in EUR Millions) Total Equity Total Debt Cash & Short Term Investments
2019-09-30 9,782.00 4,110.00 998.00
2019-06-30 8,921.00 4,878.00 914.00
2019-03-31 8,722.00 4,444.00 843.00
2018-12-31 8,924.00 4,150.00 833.00
2018-09-30 8,676.00 4,682.00 546.00
2018-06-30 8,228.00 4,051.00 311.00
2018-03-31 7,799.00 4,169.00 270.00
2017-12-31 3,533.00 12,530.00 420.00
2017-09-30 3,289.00 10,993.00 210.00
2016-09-30 2,407.00 9,593.00 239.00
2015-09-30 3,728.00 8,498.00 100.00
  • Siemens Healthineers's level of debt (41.9%) compared to net worth is high (greater than 40%).
  • Unable to establish if Siemens Healthineers's debt level has increased without past 5-year debt data.
  • Debt is well covered by operating cash flow (39.4%, greater than 20% of total debt).
  • Interest payments on debt are well covered by earnings (EBIT is 27x coverage).
X
Financial health checks
We assess Siemens Healthineers's financial health by checking for:
  1. Are short term assets greater than short term liabilities? (1 check)
  2. Are short term assets greater than long term liabilities? (1 check)
  3. Has the debt to equity ratio increased in the past 5 years? (1 check)
  4. Is the debt to equity ratio over 40%? (1 check)
  5. Is the debt covered by operating cash flow? (1 check)
  6. Are earnings greater than 5x the interest on debt (if company pays interest at all)? (1 check)
  7. Siemens Healthineers has a total score of 4/6, see the detailed checks below.
For companies that are loss making and have been so on average in the past we replace the last 2 checks with:
  1. Does cash and short term investments cover stable operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)
  2. Does cash and short term investments cover growing operating expenses (recurring G&A and R&D) for more than 3 years? (1 check)


Full details on the Health part of the Simply Wall St company analysis model.

SHL Dividends

 What is Siemens Healthineers's current dividend yield, its reliability and sustainability?

Dividends are regular cash payments to you from the company, similar to a bank paying you interest on a savings account.
Annual Dividend Income
Dividend payments
1.83%
Current annual income from Siemens Healthineers dividends. Estimated to be 2.35% next year.
If you bought CHF2,000 of Siemens Healthineers shares you are expected to receive CHF37 in your first year as a dividend.
Dividend Amount
Here we look how much dividend is being paid, if any. Is it above what you can get in a savings account? It is up there with the best dividend paying companies?
  • Siemens Healthineers's pays a lower dividend yield than the bottom 25% of dividend payers in Switzerland (1.85%).
  • Siemens Healthineers's dividend is below the markets top 25% of dividend payers in Switzerland (3.63%).
Annualized Historical and Future Dividends
It is important to see if the dividend for a company is stable, and not wildly increasing/decreasing each year. This graph shows you the historical rate to count toward your assessment of the stock.

We also check to see if the dividend has increased in the past 10 years.
Raw Data
SWX:SHL Annualized Past and Future Dividends
Data Point Source Value
Past Annualized Dividend Yield S&P Global Market Data See Below
Past Dividends per Share Company Filings/ Annualized Dividend Payments See Below
Future Dividends per Share Estimates Average of up to 19 Analyst Estimates (S&P Global) See Below
Switzerland Medical Equipment Industry Average Dividend Yield Market Cap Weighted Average of 5 Stocks 1%
Switzerland Market Average Dividend Yield Market Cap Weighted Average of 163 Stocks 2.9%
Switzerland Minimum Threshold Dividend Yield 10th Percentile 1.2%
Switzerland Bottom 25% Dividend Yield 25th Percentile 1.8%
Switzerland Top 25% Dividend Yield 75th Percentile 3.6%

Industry and Market average data is calculated daily.

Note all dividend per share amounts are annualized and not quarterly or other period.

SWX:SHL Future Dividends Estimate Data
Date (Data in €) Dividend per Share (annual) Avg. No. Analysts
2024-09-30 1.64 1.00
2023-09-30 1.42 2.00
2022-09-30 1.14 7.00
2021-09-30 1.02 18.00
2020-09-30 0.92 19.00
2019-11-14
SWX:SHL Past Annualized Dividends Data
Date (Data in €) Dividend per share (annual) Avg. Yield (%)
2019-11-04 0.800 1.868
2018-11-21 0.700 1.919
2018-11-05 0.700 1.856

Learn more about our ratios and growth rates in Simply Wall St’s analysis model >

  • It is too early to tell whether Siemens Healthineers has stable dividend payments.
  • Siemens Healthineers only just started paying a dividend, it is too early to tell if payments are increasing.
Current Payout to shareholders
What portion of Siemens Healthineers's earnings are paid to the shareholders as a dividend.
  • Dividends paid are covered by earnings (2x coverage).
Future Payout to shareholders
  • Dividends after 3 years are expected to be covered by earnings (2x coverage).
X
Income/ dividend checks
We assess Siemens Healthineers's dividend by checking for:
  1. Firstly is the company paying a notable dividend (greater than 1.2%) - if not then the rest of the checks are ignored.
  2. Is current dividend yield above the bottom 25% of dividend payers? (1 check)
  3. Is current dividend yield above the top 25% of dividend payers? (1 check)
  4. Have they paid a dividend for 10 years, and during this period has the dividend been volatile (drop of more than 25%)? (1 check)
  5. If they have paid a dividend for 10 years has it increased in this time? (1 check)
  6. How sustainable is the dividend, can Siemens Healthineers afford to pay it from its earnings today and in 3 years (Payout ratio less than 90%)? (2 checks)
  7. Siemens Healthineers has a total score of 2/6, see the detailed checks below.


Full details on the Dividends part of the Simply Wall St company analysis model.

SHL Management

 What is the CEO of Siemens Healthineers's salary, the management and board of directors tenure and is there insider trading?

Management is one of the most important areas of a company. We look at unreasonable CEO compensation, how long the team and board of directors have been around for and insider trading.
CEO
Bernd Montag
COMPENSATION €2,722,000
AGE 50
TENURE AS CEO 4.8 years
CEO Bio

Dr. Bernhard Montag, also known as Bernd, has been the President, Chief Executive Officer and Member of Management Board at Siemens Healthineers AG since 2015 and March 1, 2018 respectively. Dr. Montag began his career at the University of Nuremberg-Erlangen, Germany, as a research fellow at the Institute for Theoretical Physics in 1993 before joining Siemens’ healthcare business in 1995. From 1997 to 2004, he held various positions in the Computed Tomography and Magnetic Resonance business units within the Siemens healthcare business, including Export Sales Manager, Market Segment Manager and Head of Marketing for the business unit Magnetic Resonance, prior to becoming the CEO of the Computed Tomography business unit in 2004. Between 2008 and 2015, he first served as CEO for the Siemens Healthcare Imaging and IT division and then as CEO of the Division Imaging and Therapy Systems. He studied at the University of Nuremberg-Erlangen, Germany, where he received a diploma and PhD in physics.

CEO Compensation
  • Insufficient data for Bernd to compare compensation growth.
  • Bernd's remuneration is about average for companies of similar size in Switzerland.
Management Team Tenure

Average tenure and age of the Siemens Healthineers management team in years:

1.9
Average Tenure
55
Average Age
  • The average tenure for the Siemens Healthineers management team is less than 2 years, this suggests a new team.
Management Team

Bernd Montag

TITLE
President
COMPENSATION
€3M
AGE
50
TENURE
4.8 yrs

Jochen Schmitz

TITLE
CFO & Member of Management Board
COMPENSATION
€2M
AGE
53
TENURE
1.9 yrs

Michael Reitermann

TITLE
Chief Markets & Diagnostics Officer and Member of Management Board
COMPENSATION
€2M
AGE
57
TENURE
1.7 yrs

Marc Koebernick

TITLE
Head of Investor Relations

Michel Therin

TITLE
President of Advanced Therapies
AGE
58
Board of Directors Tenure

Average tenure and age of the Siemens Healthineers board of directors in years:

1.7
Average Tenure
55
Average Age
  • The average tenure for the Siemens Healthineers board of directors is less than 3 years, this suggests a new board.
Board of Directors

Michael Sen

TITLE
Chairman of Supervisory Board
AGE
51
TENURE
1.8 yrs

Norbert Gaus

TITLE
Deputy Chairman of Supervisory Board
COMPENSATION
€105K
AGE
58
TENURE
1.8 yrs

Ralf Peter Thomas

TITLE
Member of Supervisory Board
AGE
58
TENURE
1.7 yrs

Marion Helmes

TITLE
Member of the Supervisory Board
COMPENSATION
€84K
AGE
54
TENURE
1.7 yrs

Andreas Hoffmann

TITLE
Member of Supervisory Board
COMPENSATION
€113K
AGE
55
TENURE
1.7 yrs

Greg Sorensen

TITLE
Member of Supervisory Board
COMPENSATION
€89K
AGE
57
TENURE
1.7 yrs

Karl-Heinz Streibich

TITLE
Member of Supervisory Board
COMPENSATION
€89K
AGE
67
TENURE
1.7 yrs

Philipp Rösler

TITLE
Member of Supervisory Board
COMPENSATION
€60K
AGE
46
TENURE
1.7 yrs

Nathalie von Siemens

TITLE
Member of Supervisory Board
COMPENSATION
€69K
AGE
48
TENURE
1.7 yrs
Who owns this company?
Recent Insider Trading
  • No 3 month open market individual insider trading information.
Recent Insider Transactions
Announced Type Name Entity Role Start End Shares Max Price (CHF) Value (CHF)
X
Management checks
We assess Siemens Healthineers's management by checking for:
  1. Is the CEO's compensation unreasonable compared to market cap? (1 check)
  2. Has the CEO's compensation increased more than 20% whilst the EPS is down more then 20%? (1 check)
  3. Is the average tenure of the management team less than 2 years? (1 check)
  4. Is the average tenure of the board of directors team less than 3 years? (1 check)
  5. Siemens Healthineers has a total score of 0/6, this is not included on the snowflake, see the detailed checks below.


Note: We use the top 6 management executives and board members in our calculations.

Note 2: Insider trading include any internal stakeholders and these transactions .

Full details on the Management part of the Simply Wall St company analysis model.

SHL News

Simply Wall St News

SHL Company Info

Description

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services worldwide. The company’s Imaging segment offers magnetic resonance, computed tomography, X-ray, molecular imaging, and ultrasound systems. Its Advanced Therapies segment produces integrated products, solutions, and services for therapy departments of healthcare providers. This segment’s principal products include angiography systems and mobile C-arms. The company’s Diagnostics segment offers diagnostic products and services to healthcare providers in laboratory, molecular, and point-of-care diagnostics, including critical and chronic care. Siemens Healthineers AG also provides customer value chain services, including consulting, design, maintenance, operational management, training, and education services. The company is headquartered in Erlangen, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Details
Name: Siemens Healthineers AG
SHL
Exchange: SWX
Founded:
€47,362,329,744
998,450,654
Website: http://www.healthcare.siemens.de
Address: Siemens Healthineers AG
Henkestrasse 127,
Erlangen,
Bavaria, 91052,
Germany
Listings
Exchange Symbol Ticker Symbol Security Exchange Country Currency Listed on
XTRA SHL Ordinary Shares XETRA Trading Platform DE EUR 16. Mar 2018
OTCPK SEMH.F Ordinary Shares Pink Sheets LLC US USD 16. Mar 2018
DB SHL Ordinary Shares Deutsche Boerse AG DE EUR 16. Mar 2018
LSE 0PMJ Ordinary Shares London Stock Exchange GB EUR 16. Mar 2018
SWX SHL Ordinary Shares SIX Swiss Exchange CH CHF 16. Mar 2018
WBAG SHL Ordinary Shares Wiener Boerse AG AT EUR 16. Mar 2018
BATS-CHIXE SHLD Ordinary Shares BATS 'Chi-X Europe' GB EUR 16. Mar 2018
OTCPK SMMN.Y UNSPON ADR EACH REP 0.50 ORD SHS Pink Sheets LLC US USD 14. May 2018
DB SHL1 UNSPON ADR EACH REP 0.50 ORD SHS Deutsche Boerse AG DE EUR 14. May 2018
Number of employees
Current staff
Staff numbers
52,000
Siemens Healthineers employees.
Industry
Health Care Equipment
Healthcare
Company Analysis and Financial Data Status
Area Date (UTC time)
Company Analysis updated: 2019/11/14 22:09
End of day share price update: 2019/11/14 00:00
Last estimates confirmation: 2019/11/14
Last earnings filing: 2019/11/04
Last earnings reported: 2019/09/30
Last annual earnings reported: 2019/09/30


All dates and times in UTC. All financial data provided by Standard & Poor’s Capital IQ.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.